GM23421
LCL from B-Lymphocyte
Description:
EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT; EDMD2
LAMIN A/C; LMNA
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Muscular Dystrophies
CMD Specific |
| Class |
Congenital Muscle Diseases |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Race
|
White
|
|
Ethnicity
|
Not Hispanic/Latino
|
|
Family History
|
N
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Gene |
LMNA |
| Chromosomal Location |
1q21.2 |
| Allelic Variant 1 |
R249Q; EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT |
| Identified Mutation |
ARG249GLN |
| Remarks |
Clinically affected; no family history; lower extremity weakness; walks with no assistance; falls when tired; paroxysmal atrial fibrillation; nonsustained ventricular tachycardia; first degree AV block; Bell's palsy; moderate lumbar lordosis; some difficulty with tandem gait; donor subject has a G>A transition at nucleotide 746 in exon 4 of the LMNA gene (746G>A) resulting in the substitution of glutamine for arginine at codon 249 [Arg249Gln (R249Q)] |
| Split Ratio |
1:5 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|